BioNTech SE - ADR vs First Citizens BancShares Inc — how do they compare? BioNTech SE - ADR trades at $92.46 (market cap $23.30B), while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: BioNTech SE - ADR and First Citizens BancShares Inc are close in size by market cap, and First Citizens BancShares Inc pays a 0.37% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | FCNCA | |
|---|---|---|
Market Cap | $23.30B | $25.26B |
Sector | Health | Sector/Thematic |
52-Week High | $119.34 | $2.27K |
52-Week Low | $83.89 | $1.64K |
Enterprise Value | $6.60B | — |
Dividend Yield | — | 0.37% |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →